The study was a parallel control design trial for 2 weeks. Patients with schizophrenia were treated with 10-Hz rTMS on left motor cortex (added to the ongoing treatment). Clinical symptoms and MEP were assessment before and after rTMS treatment.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
The diagnosis of schizophrenia according to DSM-IV;
At least two item of Abnormal Involuntary Movement Scale(AIMS) must be 2 points or higher
these symptoms are not from Parkinson,tourette's syndrome,huntington disease
Signed an informed consent
You may not be if
rTMS contraindications: intracranial metal substance, with heart pacemakers and cochlear implants, intracranial pressure
patients to be diagnosed according to DSM-IV for substance abused, development delayed
current treatment with anticonvulsant acting drugs such as anticonvulsants, benzodiazepines
Acute risk of suicide and impulse
history of epileptic seizures or the presence of epileptic activity documented on the basis of EEG